Latest Insights on FIT

Something Different, but Worth Watching Over the last few years, the way people think about investing has changed radically. After the pandemic panic of 2020, people stopped talking about companies. They started talking about “gains” instead...
What is the top biotech stock pick for 2023? The #1 Breakthrough Biotech Stock for 2023 CRISPR Therapeutics is dedicated to 2 things: genetics research and saving lives. find out why this biotech stock is our #1 pick for 2023!
No Edge, No Win "To know what everyone knows is to know nothing.” I’ve shared that saying before many times. But I can’t stress it enough. This simple idea is the key to success in any endeavor, not just trading the markets...
3 Fears of a Mad and Macabre Market Inflation, bad earnings reports, ridiculous tweets from psychotic CEOs… All of these things cause our hearts to race, beating rapidly through the floorboards, a tell-tale trader now in full panic...
What I Learned From the Greed Gauge I’ve studied the market for years, testing dozens of indicators. But I’ve never seen anything like the Greed Gauge...

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

Share This